kumar-igmposter_enhancer_2013_final

1
RESEARCH POSTER PRESENTATION DESIGN © 2012 www.PosterPresentations.com Large portions of our genome contain important regulatory functions which remain uncharacterized. Bioinformatic (e.g. conservation 1 ) and biochemical (e.g. ChIP-seq 2,3 ) approaches have provided significant inroads into identifying non-coding regions of the genome with potential regulatory functions. New studies and methods are necessary to characterize the functional activity of these putative regulatory regions and specificity in complex tissues such as the skin. The skin consists of multiple layers and cell types. In the skin, many of the cells express genes from three clustered loci, which contain keratin and barrier-function genes 4-6 . Coding and non- coding regions of these clusters are frequently implicated in genetic conditions. Like other clustered loci, these loci are highly conserved (Fig. 1) and are thought to retain this organization due to selective pressures to maintain regulatory networks necessary for co- expressed genes. Notably, differential expression of genes located in the three clusters often distinguish specific layers and cell types. Thus, regulatory domains within these clusters likely control spatial and cell-type specific gene expression. The methods to test the spatial activity of epithelial enhancers however remain limited. In the definitive epidermis, at least four stages of development can be identified: basal, spinous, granular, and cornified envelope keratinocytes (Fig. 2). While during early development, these four stages appear in temporal order, emerging evidence from our lab and others suggest additional mechanisms play a role in the spatial identity of each layer. To address spatial regulation of keratin and barrier genes in the definitive epidermal tissue, we have identified a mouse model in which specific epithelial identities are absent from which P300 ChIP-seq was performed (Fig. 2). P300 sites which are lost in these mice are likely to correspond to regulatory regions important for layer-specific gene expression. Following identification of putative layer-specific enhancers, their activity was assayed through cell-based and a modified graft-based assay. Notably, this latter assay provides for a simple, high-throughput method to determine the spatial regulatory activity of epidermal enhancers. GOALS RESULTS (continued) RESULTS (continued) REFERENCES ACKNOWLEDGEMENTS Division of Dermatology 1 , Department of Medicine 2 , Institute for Genomic Medicine 3 , Ludwig Cancer Institute 4 , Dept. of Cellular Molecular Medicine 5 , School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA. Shantanu Kumar 1-3 , Suguna R. Krishnaswami 1-3 , Drew Grainger 1-3 , Christopher Adase 1-3 , Craig Ricker 1-3 , Y. Shen 4,5 , Bing Ren 3,4,5 , and Benjamin D. Yu 1-3 A high-throughput approach to validate enhancers responsible for spatial patterning in the skin RESULTS & CONCLUSION A major goal of this study was to systematically identify and validate regulatory domains within clustered loci which are active in the skin, keratin type I (KC1), keratin type II (KC2), and epidermal differentiation complex (EDC). Using a mouse model where intermediate cell types are lost, we observed a loss of ~50% of P300 sites within the KC2 locus (Fig 3). Regulatory changes occur at these sites, including H3K27ac, in mutant vs. wildtype epithelium and during normal embryonic development (Fig. 4). Experimental validation of enhancer activity showed ~80% of putative layer- specific mouse enhancers activate in response to differentiation in a human keratinocyte differentiation assay (Fig. 5). A graft-based assay was developed to reproduce the organization of epidermal development (Fig. 6) and to identify layer-specific activity of putative enhancers (Fig. 7). Overall, this approach allows for the rapid assessment of epidermal regulatory elements embedded within clustered loci. Fig. 2. Spatial organization of the definitive epidermis (Left) Progenitors located in the stratum basale (sb) divide and give rise to post-mitotic daughter cells which move upward in the stratum spinousum (ss). Upon further differentiation, cells again move upward to the stratum granulosum (sg) layer and then the stratum corneum (sc). (Right) In hyperproliferative conditions such as psoriasis, intermediate cell types are often lost. This condition is also seen in children with congenital mutations in BRAF, e.g. cardiofaciocutaneous syndrome. Fig. 6. Validation of epidermal engraftment model. (A) Epidermal cysts form in nu/nu mice injected with human neonatal keratinocytes. One week after injection, cysts are sectioned and stained (B) Staining of cysts for basal K14 (red) and spinous markers K10 (green) (C) Multiple epidermal stages spontaneously form in cyst model. Basal layer (KRT5/14 pos ), spinous (Krt1/10 pos ), granular (green FLG pos ; not shown), final layer, cornifiied envelope (Lce3a/3b pos ) in situ hybridization is shown. Implanted keratinocytes generate layered cysts which recapitulate spatial pattern of epidermis Fig. 1. Conservation within the keratin type II cluster (KC2). Strong conservation within intergenic regions (red) can be identified in visual- ization from ECR Browser (Ovcharenko 2004). Peaks demonstrate conservation over 50%. Fig. 4. Increase H3K27ac at putative enhancers during appear- ance of differentiated layers in the E14.5 -> E17.5 epidermis. (A) Differentiated layers appear between E14.5 to E18.5. (B) Wildtype H3K4me1 changes at P300-sites between E14.5-17.5. (C) Wildtype H3K27ac increases between E14.5-17.5. Note: first two columns represent enhancer sites which do not change (positive controls). Putative layer-specific enhancers identified by differential P300 occupancy Putative layer-specific enhancers show increased H3K27 acetylation during development 1. Ovcharenko et al (2004) Nucleic Acids Research 32: W280-W286 2. Heintzman ND et al (2007) Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 39: 311–318. 3. Visel A et al (2009) ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 457: 854–858 4. Bossuyt F (2012) Radiation and functional diversification of alpha keratins during early vertebrate evolution. Mol Bio Evol 29(3):995-1004 5. Romano V (1997) Human type I cytokeratin genes are a compact cluster. Cytogenet Cell Genet 77(3-4):169-174 6. Segre JA (2010) A milieu of regulatory elements in the epidermal differentiation complex syntenic block: implications for atopic dermatitis and psoriasis. Hum Mol Genet 19(8):1453-1460. 7. Visel A et al (2007). VISTA Enhancer Browser-a database of tissue- specific human enhancers. Nucleic Acids Res 35:D88-92 INTRODUCTION RESULTS (continued) Fig. 7. Enhancer drives spatial activation of GFP reporter consistent with granular layer-specific activity. (A) Low power view of epidermal cyst 1 week after injection in brightfield, positive fluorescence in unfixed tissue and merged image. (B) Immunofluorescent staining of cyst wall demonstrates spatial patterning of epidermis, basal (red, P63), spinous (red, KRT10), involucrin (red, IVL), and stage-specific activation of GFP (green, anti-GFP). c = P300 loci present in both wt and mutant Change in enrichment from E14.5 to E17.5 epidermis spinous spinous + granular mature basal WT BRAF VE H3K27Ac LICR/ENCODE (H3K4me1) multiple tissues (non-epidermal) Braf VE YU (P300, E17.5 epidermis) • • • • • • • •• UCSC Tracks wt 10 kb Fig. 3. P300 ChIP-seq analysis of wildtype and BRAF epidermis and loss of putative enhancers in mutant epidermis. (A) Loss of intermediate stages of epidermal differentiation in K14-cre; Braf V600E E17.5 mice. Earlier to later steps in differentiation are ordered from bottom to top and detected by in situ hybridization. (B) Pooled mouse epidermis from four control and four mutant E17.5 embryos were used for P300 ChIP-seq. (C) Novel putative enhancers in mouse epidermis relative to non-skin enhancers; loss of specific P300-loci (red circles) in Braf V600E mice. . 60 µM calcium (undifferentiated) 1.5 mM calcium (differentiated) Putative layer-specific enhancers activate reporter expression in upper layers of cysts A B A B A B A B C A B C C Fig. 5. Cell-based keratinocyte differentiation assay (A) Schematic of cell-based assay. High calcium condition induces differentiation of human keratinocytes in 3 days. (B) Generation of lentiviral reporters (enhancer + minimal Hsp68 promoter- GFP [Ref. 7]). Introduction of reporter in human keratinocyte and demonstration of activity in differentiation media vs. non-differentiating media. (Bottom panel, green) represents merge images of brightfield/GFP of loci 3-46. >80% of layer-specific enhancers activate during differentiation. P63 (basal) GFP KRT10 (spinous) GFP IVL (granular) GFP ACKNOWLEDGEMENTS This work was supported by generous grants from the NIH/NIAMS , California Institute for Regenerative Medicine RN2-00908, and institutional funds to B.D.Y.. H3K4me1 H3K27ac % Change % Change normal hyperproliferative conditions Control MuKrt71-200 MuKrt71-800 MuKrt5-792 MuIGRKrt5-402 MuKrt5-65 (1) (2) (3) (4) (7) min promoter - + phase diff - + - + Putative layer-specific enhancers drive reporter expression in cell-based differentiation assays c c 1-40 putative layer-specific enhancers c c 1-40 putative layer-specific enhancers sb ss sg 200K – 1 million human keratinocytes 6-8 subcut sites 1 week E8.5 E9.5 E14.5 E15.5 E16.5 E17.5

Upload: shantanu-kumar

Post on 13-Feb-2017

89 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Kumar-igmposter_enhancer_2013_FINAL

QUICK TIPS (--THIS SECTION DOES NOT PRINT--)

This PowerPoint template requires basic PowerPoint (version 2007 or newer) skills. Below is a list of commonly asked questions specific to this template. If you are using an older version of PowerPoint some template features may not work properly.

Using the template

Verifying the quality of your graphics Go to the VIEW menu and click on ZOOM to set your preferred magnification. This template is at 100% the size of the final poster. All text and graphics will be printed at 100% their size. To see what your poster will look like when printed, set the zoom to 100% and evaluate the quality of all your graphics before you submit your poster for printing. Using the placeholders To add text to this template click inside a placeholder and type in or paste your text. To move a placeholder, click on it once (to select it), place your cursor on its frame and your cursor will change to this symbol: Then, click once and drag it to its new location where you can resize it as needed. Additional placeholders can be found on the left side of this template. Modifying the layout This template has four different column layouts. Right-click your mouse on the background and click on “Layout” to see the layout options. The columns in the provided layouts are fixed and cannot be moved but advanced users can modify any layout by going to VIEW and then SLIDE MASTER. Importing text and graphics from external sources TEXT: Paste or type your text into a pre-existing placeholder or drag in a new placeholder from the left side of the template. Move it anywhere as needed. PHOTOS: Drag in a picture placeholder, size it first, click in it and insert a photo from the menu. TABLES: You can copy and paste a table from an external document onto this poster template. To adjust the way the text fits within the cells of a table that has been pasted, right-click on the table, click FORMAT SHAPE then click on TEXT BOX and change the INTERNAL MARGIN values to 0.25 Modifying the color scheme To change the color scheme of this template go to the “Design” menu and click on “Colors”. You can choose from the provide color combinations or you can create your own.

QUICK DESIGN GUIDE (--THIS SECTION DOES NOT PRINT--)

This PowerPoint 2007 template produces a 36”x48” professional poster. It will save you valuable time placing titles, subtitles, text, and graphics. Use it to create your presentation. Then send it to PosterPresentations.com for premium quality, same day affordable printing. We provide a series of online tutorials that will guide you through the poster design process and answer your poster production questions. View our online tutorials at: http://bit.ly/Poster_creation_help (copy and paste the link into your web browser). For assistance and to order your printed poster call PosterPresentations.com at 1.866.649.3004

Object Placeholders

Use the placeholders provided below to add new elements to your poster: Drag a placeholder onto the poster area, size it, and click it to edit. Section Header placeholder Move this preformatted section header placeholder to the poster area to add another section header. Use section headers to separate topics or concepts within your presentation. Text placeholder Move this preformatted text placeholder to the poster to add a new body of text. Picture placeholder Move this graphic placeholder onto your poster, size it first, and then click it to add a picture to the poster.

RESEARCH POSTER PRESENTATION DESIGN © 2012

www.PosterPresentations.com

©  2012  PosterPresenta.ons.com          2117  Fourth  Street  ,  Unit  C          Berkeley  CA  94710          [email protected]  

Student discounts are available on our Facebook page. Go to PosterPresentations.com and click on the FB icon.

Large portions of our genome contain important regulatory functions which remain uncharacterized. Bioinformatic (e.g. conservation1) and biochemical (e.g. ChIP-seq2,3) approaches have provided significant inroads into identifying non-coding regions of the genome with potential regulatory functions. New studies and methods are necessary to characterize the functional activity of these putative regulatory regions and specificity in complex tissues such as the skin. The skin consists of multiple layers and cell types. In the skin, many of the cells express genes from three clustered loci, which contain keratin and barrier-function genes4-6. Coding and non-coding regions of these clusters are frequently implicated in genetic conditions. Like other clustered loci, these loci are highly conserved (Fig. 1) and are thought to retain this organization due to selective pressures to maintain regulatory networks necessary for co-expressed genes. Notably, differential expression of genes located in the three clusters often distinguish specific layers and cell types. Thus, regulatory domains within these clusters likely control spatial and cell-type specific gene expression. The methods to test the spatial activity of epithelial enhancers however remain limited.

In the definitive epidermis, at least four stages of development can be identified: basal, spinous, granular, and cornified envelope keratinocytes (Fig. 2). While during early development, these four stages appear in temporal order, emerging evidence from our lab and others suggest additional mechanisms play a role in the spatial identity of each layer. To address spatial regulation of keratin and barrier genes in the definitive epidermal tissue, we have identified a mouse model in which specific epithelial identities are absent from which P300 ChIP-seq was performed (Fig. 2). P300 sites which are lost in these mice are likely to correspond to regulatory regions important for layer-specific gene expression. Following identification of putative layer-specific enhancers, their activity was assayed through cell-based and a modified graft-based assay. Notably, this latter assay provides for a simple, high-throughput method to determine the spatial regulatory activity of epidermal enhancers.

GOALS

RESULTS (continued) RESULTS (continued)

REFERENCES

ACKNOWLEDGEMENTS

Division of Dermatology1, Department of Medicine2, Institute for Genomic Medicine3, Ludwig Cancer Institute4, Dept. of Cellular Molecular Medicine5, School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.

Shantanu Kumar1-3, Suguna R. Krishnaswami1-3, Drew Grainger1-3, Christopher Adase1-3, Craig Ricker1-3, Y. Shen4,5, Bing Ren3,4,5, and Benjamin D. Yu1-3

A high-throughput approach to validate enhancers responsible for spatial patterning in the skin

RESULTS & CONCLUSION A major goal of this study was to systematically identify and validate regulatory domains within clustered loci which are active in the skin, keratin type I (KC1), keratin type II (KC2), and epidermal differentiation complex (EDC). Using a mouse model where intermediate cell types are lost, we observed a loss of ~50% of P300 sites within the KC2 locus (Fig 3). Regulatory changes occur at these sites, including H3K27ac, in mutant vs. wildtype epithelium and during normal embryonic development (Fig. 4). Experimental validation of enhancer activity showed ~80% of putative layer-specific mouse enhancers activate in response to differentiation in a human keratinocyte differentiation assay (Fig. 5). A graft-based assay was developed to reproduce the organization of epidermal development (Fig. 6) and to identify layer-specific activity of putative enhancers (Fig. 7). Overall, this approach allows for the rapid assessment of epidermal regulatory elements embedded within clustered loci.

Fig. 2. Spatial organization of the definitive epidermis (Left) Progenitors located in the stratum basale (sb) divide and give rise to post-mitotic daughter cells which move upward in the stratum spinousum (ss). Upon further differentiation, cells again move upward to the stratum granulosum (sg) layer and then the stratum corneum (sc). (Right) In hyperproliferative conditions such as psoriasis, intermediate cell types are often lost. This condition is also seen in children with congenital mutations in BRAF, e.g. cardiofaciocutaneous syndrome.

Fig. 6. Validation of epidermal engraftment model. (A) Epidermal cysts form in nu/nu mice injected with human neonatal keratinocytes. One week after injection, cysts are sectioned and stained (B) Staining of cysts for basal K14 (red) and spinous markers K10 (green) (C) Multiple epidermal stages spontaneously form in cyst model. Basal layer (KRT5/14pos), spinous (Krt1/10pos), granular (green FLGpos; not shown), final layer, cornifiied envelope (Lce3a/3bpos) in situ hybridization is shown.

Implanted keratinocytes generate layered cysts which recapitulate spatial pattern of epidermis

Fig. 1. Conservation within the keratin type II cluster (KC2). Strong conservation within intergenic regions (red) can be identified in visual-ization from ECR Browser (Ovcharenko 2004). Peaks demonstrate conservation over 50%.

Fig. 4. Increase H3K27ac at putative enhancers during appear-ance of differentiated layers in the E14.5 -> E17.5 epidermis. (A) Differentiated layers appear between E14.5 to E18.5. (B) Wildtype H3K4me1 changes at P300-sites between E14.5-17.5. (C) Wildtype H3K27ac increases between E14.5-17.5. Note: first two columns represent enhancer sites which do not change (positive controls).

Putative layer-specific enhancers identified by differential P300 occupancy

Putative layer-specific enhancers show increased H3K27 acetylation during development

1.  Ovcharenko et al (2004) Nucleic Acids Research 32: W280-W286 2.  Heintzman ND et al (2007) Distinct and predictive chromatin signatures

of transcriptional promoters and enhancers in the human genome. Nat Genet 39: 311–318.

3.  Visel A et al (2009) ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 457: 854–858

4.  Bossuyt F (2012) Radiation and functional diversification of alpha keratins during early vertebrate evolution. Mol Bio Evol 29(3):995-1004

5.  Romano V (1997) Human type I cytokeratin genes are a compact cluster. Cytogenet Cell Genet 77(3-4):169-174

6.  Segre JA (2010) A milieu of regulatory elements in the epidermal differentiation complex syntenic block: implications for atopic dermatitis and psoriasis. Hum Mol Genet 19(8):1453-1460.

7.  Visel A et al (2007). VISTA Enhancer Browser-a database of tissue-specific human enhancers. Nucleic Acids Res 35:D88-92

INTRODUCTION RESULTS (continued)

Fig. 7. Enhancer drives spatial activation of GFP reporter consistent with granular layer-specific activity. (A) Low power view of epidermal cyst 1 week after injection in brightfield, positive fluorescence in unfixed tissue and merged image. (B) Immunofluorescent staining of cyst wall demonstrates spatial patterning of epidermis, basal (red, P63), spinous (red, KRT10), involucrin (red, IVL), and stage-specific activation of GFP (green, anti-GFP).

c = P300 loci present in both wt and mutant

Change in enrichment from E14.5 to E17.5 epidermis

spinous

spinous + granular

mature

basal

WT BRAFVE

H3K27Ac  LICR/ENCODE (H3K4me1)

mul

tiple

tiss

ues

(non

-epi

derm

al)

BrafVE

YU (P300, E17.5 epidermis)

• • • • • • • • • • • •

UCSC Tracks

wt

10 kb

Fig. 3. P300 ChIP-seq analysis of wildtype and BRAF epidermis and loss of putative enhancers in mutant epidermis. (A) Loss of intermediate stages of epidermal differentiation in K14-cre; BrafV600E E17.5 mice. Earlier to later steps in differentiation are ordered from bottom to top and detected by in situ hybridization. (B) Pooled mouse epidermis from four control and four mutant E17.5 embryos were used for P300 ChIP-seq. (C) Novel putative enhancers in mouse epidermis relative to non-skin enhancers; loss of specific P300-loci (red circles) in BrafV600E mice. .

60 µM calcium (undifferentiated)

1.5 mM calcium (differentiated)

Putative layer-specific enhancers activate reporter expression in upper layers of cysts

A

B

A B

A

B

A

B

C

A B

C

C

Fig. 5. Cell-based keratinocyte differentiation assay (A) Schematic of cell-based assay. High calcium condition induces differentiation of human keratinocytes in 3 days. (B) Generation of lentiviral reporters (enhancer + minimal Hsp68 promoter-GFP [Ref. 7]). Introduction of reporter in human keratinocyte and demonstration of activity in differentiation media vs. non-differentiating media. (Bottom panel, green) represents merge images of brightfield/GFP of loci 3-46. >80% of layer-specific enhancers activate during differentiation.

P63 (basal) GFP

KRT10 (spinous) GFP

IVL (granular) GFP

ACKNOWLEDGEMENTS This work was supported by generous grants from the NIH/NIAMS , California Institute for Regenerative Medicine RN2-00908, and institutional funds to B.D.Y..

H3K4me1

H3K27ac

% C

hang

e  

% C

hang

e  

normal hyperproliferative conditions

Control MuKrt71-200 MuKrt71-800 MuKrt5-792 MuIGRKrt5-402 MuKrt5-65 (1) (2) (3) (4) (7) min promoter

- +

phas

e di

ff

- + - +

Putative layer-specific enhancers drive reporter expression in cell-based differentiation assays

c c 1-40 putative layer-specific enhancers

c c 1-40 putative layer-specific enhancers

sb ss sg

200K – 1 million human keratinocytes 6-8 subcut sites 1 week

E8.5

E9.5

E14.5 E15.5 E16.5 E17.5